Aarti Drugs Limited — Financials & Forensics

Sector: Healthcare · NSE: AARTIDRUGS · BSE: 524348 · ISIN: INE767A01016

₹428.35

Closing price
11 Sep 2026

-16.2%

1-year price change

₹3,910 Cr

Market cap

20.1×

P/E ratio (trailing)

13.4%

Return on Equity (FY)

0.46%

Dividend yield

⚡ What you get within minutes of every filing

ISA

Indian Stock Alerts BOT

🚨 AARTIDRUGS — Quarterly Results

Revenue: ₹2,35,800 Cr (+12% YoY)

PAT: ₹19,200 Cr (+17% YoY)

EBITDA margin: 16.8%

Board declared ₹10/share dividend. Jio adds 8M subs.

📎 bseindia.com/xml-data/...

🎧 Audio summary ready

✓✓ 6:47 PM

🎧

Instant audio summaries2-min AI concall recap delivered with every earnings alert

📊

20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings

🔍

Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically

⚡

Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add AARTIDRUGS to your watchlist — all of this, automated.

14-day Pro trial · No credit card · Cancel anytime

Loading chart…

Annual P&L snapshot

Line item	FY22	FY23	FY24	FY25	FY26
Revenue from operations	₹2,489 Cr	₹2,716 Cr	₹2,529 Cr	₹2,387 Cr	₹2,565 Cr
EBITDA	₹329 Cr	₹306 Cr	₹316 Cr	₹287 Cr	₹309 Cr
EBITDA margin	13.2%	11.2%	12.5%	12.0%	12.1%
Profit after tax	₹205 Cr	₹166 Cr	₹172 Cr	₹168 Cr	₹195 Cr

Source: Aarti Drugs Limited's regulatory filings under SEBI LODR Regulation 33. View full financials →

Deeper analysis

Recent filings by Aarti Drugs Limited

Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-term St
31 Jul 2026 · Management Change
Change in Directorate
31 Jul 2026 · Management Change
Outcome of Board Meeting
31 Jul 2026 · Financial Results

Never miss a filing again

Add stocks to watchlist

Get instant Telegram alerts

Get started — it's free →

14-day Pro trial included · No credit card required

About Aarti Drugs Limited on Indian Stock Alerts

Indian Stock Alerts tracks Aarti Drugs Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.

Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.

Important. All data on this page is sourced from Aarti Drugs Limited's own public regulatory filings under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Investors should consult registered advisers before making investment decisions.